Many people assume FDA considers the VALUE of new drugs as part of their drug approval process

July 2013

Many people assume FDA considers the VALUE of new drugs as part of their drug approval process.

But they don't. By law, FDA only considers safety and efficacy...NOT the drug's cost or whether it's needed. FDA can't take into account whether we really need an 8th statin...or a 9th ARB.

This explains why manufacturers often try to protect their patents with new drugs that are only a slight twist on existing products.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote